Shenzhen, China · Founded 2014 · Privately Held (backing)
Developer of anti-cancer medical solutions intended to address drug resistance and urgent clinical needs through next-generation small-molecule therapies. Tajiri is based in Shenzhen, China and was founded in 2014. Its last reported valuation was $146 million in Apr 2020. It has raised $85.8 million.
Last reported valuation
$145.6M
Oct 2026
Priced at
—
Total raised
$85.8M
Last round
—
Cap table — not yet on record
Tajiri's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tajiri with a free account
·The complete investor list: 12 names
·Watch Tajiri: the Monday email on marks, rounds and moves
